-Currently founder of Alykomed Global Solutions LLC, strategizes with C-level corporate teams on M&A, raising capital -Founded Intercept Pharmaceuticals non-invasive biomarker group- Phase II/III clinical programs, external collaborations. -CSO of Oncostem Biotherapeutics- preclinical strategy -Founding Biomarker Council Chairman, ICAN- leads world class team of ~40 leading industry/academic scientists -PI of academic research groups at Columbia University- collaborated with academic and clinical thought leaders, and industry groups (large-cap companies, innovators) - Matrix environment- established/led cross-functional, multidimensional, internal-external, project focused teams